Innovent Biologics, Inc. (IVBXF)
OTCMKTS
· Delayed Price · Currency is USD
5.94
0.00 (0.00%)
May 14, 2025, 4:00 PM EDT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $10.56 billion as of May 15, 2025. Its market cap has increased by 51.15% in one year.
Market Cap
10.56B
Enterprise Value
9.87B
Revenue
1.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.94
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 10.56B, an increase of 346.49%. That is a compound annual growth rate of 25.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 712.65M |
| Tian'an Technology Group | 591.73M |
| CytoDyn | 510.85M |
| Glass House Brands | 479.77M |
| Elite Pharmaceuticals | 458.29M |
| Northwest Biotherapeutics | 413.23M |